Global health policy is the subfield concerned with the goals, instruments, and governance of cross-border health interventions. Its history is defined by a persistent, unresolved tension: should policy prioritize controlling specific diseases through targeted, measurable programs, or should it build comprehensive systems that address the underlying social determinants of health? This vertical-versus-horizontal struggle has shaped every major policy framework, and understanding it is key to navigating the field today.
After World War II, the dominant paradigm was International Health, embodied by the newly formed World Health Organization (WHO) and a network of bilateral aid agencies. The policy problem was defined as the spread of infectious diseases across borders, and the solution lay in technical assistance: disease surveillance, vaccination campaigns, and the transfer of medical knowledge from wealthier to poorer nations. The legitimate actors were national governments, international organizations, and medical experts. This framework operated on the assumption that health improvements would follow from economic development and the diffusion of biomedical technology. It was a top-down, state-centered model that largely ignored local social conditions and community participation. International Health provided the institutional and conceptual foundation for later frameworks, but its narrow focus on vertical disease control soon faced a powerful challenge.
The 1978 Alma-Ata Conference on Primary Health Care marked a watershed. The declaration it produced championed Comprehensive Primary Health Care (CPHC), a framework that defined health as a human right and called for intersectoral action on social and economic determinants. CPHC proposed community participation, local health workers, and integration of preventive and curative services. It was explicitly horizontal: building sustainable systems from the ground up. But within a year, a rival framework emerged. In 1979, a Rockefeller Foundation conference in Bellagio produced a critique arguing that CPHC was too idealistic, costly, and unmeasurable. The alternative was Selective Primary Health Care and Vertical Disease Control (SPHC), which narrowed the goal to a handful of cost-effective technical interventions—most famously, the GOBI-FFF strategy (growth monitoring, oral rehydration, breastfeeding, immunization, family planning, and food supplements). SPHC did not reject CPHC outright; rather, it coexisted as a pragmatic, measurable rival that attracted major funding from bilateral donors and organizations like UNICEF. The two frameworks embodied the core tension: CPHC sought social transformation; SPHC sought efficient delivery of targeted services. This split determined global health policy for decades, with SPHC dominating practice while CPHC remained a rhetorical anchor.
In the 1990s, a new kind of policy infrastructure emerged. The Global Burden of Disease Framework (GBD), launched in 1990 by the World Bank and WHO, quantified mortality and morbidity using the Disability-Adjusted Life Year (DALY). GBD provided a common metric for comparing diseases and interventions, making cost-effectiveness the central criterion for priority-setting. This framework did not replace CPHC or SPHC; instead, it supplied the analytical tools that later made SPHC's logic more systematic. GBD’s data became the evidence base for policy decisions, often reinforcing vertical priorities by showing high burdens from a few diseases.
Around 2000, a different policy logic emerged. The Global Health Security (GHS) framework reframed health as a security issue. The 2001 anthrax attacks, the SARS outbreak of 2003, and the International Health Regulations revision positioned infectious disease outbreaks as threats to national and global security. GHS prioritized surveillance, rapid response, and containment—a vertical approach focused on high-consequence pathogens. Its actors included not just health ministries but also security agencies, militaries, and international bodies like the UN Security Council. GHS competed directly with horizontal frameworks for attention and resources, especially after the 2014 Ebola outbreak.
In parallel with the security turn, the policy community began to address the fragmentation caused by decades of vertical programs. The Health Systems Strengthening and Universal Health Coverage (HSS/UHC) framework, emerging around 2000, revived the horizontal ambition of CPHC but with a new institutional focus. Instead of community participation, HSS/UHC emphasized building functional health systems: financing, workforce, information, and service delivery. UHC in particular aimed to ensure all people can access needed services without financial hardship, often through insurance schemes or pooled funds. This framework absorbed the comprehensive concern for equity but operationalized it through system-level metrics and fiscal policy. It coexisted with GHS and GBD, sometimes in tension when funding for disease-specific programs diverted resources from system strengthening.
Also around 2000, Global Health Governance (GHG) emerged as a framework for analyzing the new multi-actor landscape. GHG examined how the proliferation of actors—private foundations, NGOs, public-private partnerships like the Global Fund—changed policy-making. It did not prescribe a single policy solution but rather investigated how power, norms, and institutions shape health outcomes. GHG complemented HSS/UHC by highlighting governance gaps and the need for coordination, without itself being a direct competitor to vertical programs.
The 2010s brought two frameworks that fundamentally challenged the premises of all earlier policy models. Decolonizing Global Health questioned the field's power structures: who sets priorities, who controls funding, and whose knowledge counts. It criticized International Health's paternalism, SPHC's external imposition, and even HSS/UHC's technocratic bias. This framework does not offer a new set of interventions; instead, it functions as a meta-critique, arguing that global health policy itself must be re-imagined to center local agency and redress colonial legacies. It coexists with other frameworks in a state of living disagreement, pushing them to confront their own assumptions.
Social Determinants and Health Equity (SDHE) revived the comprehensive vision of CPHC but with a sharper analytical lens. The 2008 WHO Commission on Social Determinants of Health documented how inequities in power, money, and resources drive health outcomes. SDHE does not reject GBD’s metrics but argues they must be supplemented by data on social gradients and political determinants. It overlaps with Decolonizing Global Health in its critique of inequality, but it is more policy-prescriptive, calling for intersectoral action on housing, education, and income. SDHE can be seen as a specification and reinforcement of CPHC’s original agenda, adapted to the evidence base of the 21st century.
Today, no single framework dominates global health policy. The field is a contested arena where competing paradigms vie for funding, institutional mandates, and legitimacy. The leading frameworks—HSS/UHC, GHS, GBD-influenced priority-setting, and SDHE—agree on broad goals like reduced mortality and equity, but they disagree sharply on means. HSS/UHC champions system building and financial protection; GHS insists on preparedness and surveillance; GBD-driven approaches advocate cost-effective vertical programs; SDHE demands action on social roots of disease. These frameworks overlap in practice: for example, GHS now incorporates some health system strengthening to build response capacity, and UHC advocates use GBD data to justify investments. Yet tensions remain acute: should a country invest in a new vaccine program (vertical) or in primary care clinics (horizontal)? Should funding prioritize pandemic prevention or chronic disease management? The answer depends on which framework’s logic prevails in a given policy moment. Global health policy thus remains a field of enduring disagreement, where the vertical-horizontal divide is unlikely to be resolved but must be continuously negotiated.